Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2006

Open Access 01-12-2006 | Case report

Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature

Authors: K Tsalis, K Blouhos, K Vasiliadis, T Tsachalis, S Angelopoulos, D Betsis

Published in: World Journal of Surgical Oncology | Issue 1/2006

Login to get access

Abstract

Background

The Muir-Torre syndrome is a rare autosomal dominant condition and is currently considered a subtype of the more common hereditary nonpolyposis colorectal cancer syndrome, in which multiple primary malignancies occur together with sebaceous gland tumors.

Case presentation

We describe a case of a 62-year-old woman with three primary colorectal tumors, genital tumor, and sebaceous adenomas and present her family history of three generations. Our case represents the first case reported from Greece in the international literature.

Conclusion

Recognition of the syndrome in patients with sebaceous gland tumors should facilitate early detection of subsequent malignancies if the patient is entered into appropriate screening programs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pettey AA, Walsh JS: Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005, 75: 149-155.PubMed Pettey AA, Walsh JS: Muir-Torre syndrome: a case report and review of the literature. Cutis. 2005, 75: 149-155.PubMed
2.
go back to reference Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A, Benatti P, Seidenari S, Pellacani G, Lembo L, Rossi G, Marino M, Lucci-Cordisco E, de Leon MP: Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer. 2005, 103: 1018-1025. 10.1002/cncr.20873.CrossRefPubMed Ponti G, Losi L, Di Gregorio C, Roncucci L, Pedroni M, Scarselli A, Benatti P, Seidenari S, Pellacani G, Lembo L, Rossi G, Marino M, Lucci-Cordisco E, de Leon MP: Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry. Cancer. 2005, 103: 1018-1025. 10.1002/cncr.20873.CrossRefPubMed
3.
go back to reference Schwartz RA, Torre DP: The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995, 33: 90-104. 10.1016/0190-9622(95)90017-9.CrossRefPubMed Schwartz RA, Torre DP: The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol. 1995, 33: 90-104. 10.1016/0190-9622(95)90017-9.CrossRefPubMed
4.
go back to reference Muir EG, Bell AJY, Barlow KA: Multiple primary carcinomata of the colon, duodenum and larynx associated with kerato-acanthoma of the face. Br J Surg. 1967, 54: 191-195.CrossRefPubMed Muir EG, Bell AJY, Barlow KA: Multiple primary carcinomata of the colon, duodenum and larynx associated with kerato-acanthoma of the face. Br J Surg. 1967, 54: 191-195.CrossRefPubMed
5.
go back to reference Torre D: Society transactions: New York Dermatological Society, Oct 24, 1967. Arch Dermatol. 1968, 98: 549-51. 10.1001/archderm.98.5.549.CrossRefPubMed Torre D: Society transactions: New York Dermatological Society, Oct 24, 1967. Arch Dermatol. 1968, 98: 549-51. 10.1001/archderm.98.5.549.CrossRefPubMed
6.
go back to reference Akhtar S, Oza KK, Khan SA, Wright J: Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999, 41: 681-686. 10.1016/S0190-9622(99)70001-0.CrossRefPubMed Akhtar S, Oza KK, Khan SA, Wright J: Muir-Torre syndrome: case report of a patient with concurrent jejunal and ureteral cancer and a review of the literature. J Am Acad Dermatol. 1999, 41: 681-686. 10.1016/S0190-9622(99)70001-0.CrossRefPubMed
7.
go back to reference Cohen PR, Kohn SR, Davis DA, Kurzrock R: Muir-Torre syndrome. Dermatol Clin. 1995, 13: 79-89.PubMed Cohen PR, Kohn SR, Davis DA, Kurzrock R: Muir-Torre syndrome. Dermatol Clin. 1995, 13: 79-89.PubMed
8.
go back to reference Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Sanchez RL: Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol. 2003, 30: 178-184. 10.1034/j.1600-0560.2003.00010.x.CrossRefPubMed Popnikolov NK, Gatalica Z, Colome-Grimmer MI, Sanchez RL: Loss of mismatch repair proteins in sebaceous gland tumors. J Cutan Pathol. 2003, 30: 178-184. 10.1034/j.1600-0560.2003.00010.x.CrossRefPubMed
9.
go back to reference Curry ML, Eng W, Lund K, Paek D, Cockerell CJ: Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol. 2004, 26: 217-221.CrossRefPubMed Curry ML, Eng W, Lund K, Paek D, Cockerell CJ: Muir-Torre syndrome: role of the dermatopathologist in diagnosis. Am J Dermatopathol. 2004, 26: 217-221.CrossRefPubMed
10.
go back to reference Cohen PR, Kohn SR, Kurzrock R: Association of sebaceous gland tumours and internal malignancy: the Muir-Torre syndrome. Am J Medicine. 1991, 90: 606-613.CrossRef Cohen PR, Kohn SR, Kurzrock R: Association of sebaceous gland tumours and internal malignancy: the Muir-Torre syndrome. Am J Medicine. 1991, 90: 606-613.CrossRef
11.
go back to reference Chen CS, Loweinstein L, James C, Huilgol SC, Selva D: Muir-Torre syndrome and early detection of internal malignancy. Med J Aust. 2003, 178: 368-PubMed Chen CS, Loweinstein L, James C, Huilgol SC, Selva D: Muir-Torre syndrome and early detection of internal malignancy. Med J Aust. 2003, 178: 368-PubMed
12.
go back to reference Fiorentino DF, Nguyen JC, Egbert BM, Swetter SM: Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. J Am Acad Dermatol. 2004, 50: 476-478. 10.1016/j.jaad.2003.07.027.CrossRefPubMed Fiorentino DF, Nguyen JC, Egbert BM, Swetter SM: Muir-Torre syndrome: confirmation of diagnosis by immunohistochemical analysis of cutaneous lesions. J Am Acad Dermatol. 2004, 50: 476-478. 10.1016/j.jaad.2003.07.027.CrossRefPubMed
13.
go back to reference Mangold E, Pegenstecher C, Leister M, Mathiak M, Rutten A, Friedl W, Propping P, Rutzicka T, Kruse RJ: A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. Med Genet. 2004, 41: 567-572. 10.1136/jmg.2003.012997.CrossRef Mangold E, Pegenstecher C, Leister M, Mathiak M, Rutten A, Friedl W, Propping P, Rutzicka T, Kruse RJ: A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. Med Genet. 2004, 41: 567-572. 10.1136/jmg.2003.012997.CrossRef
14.
go back to reference Mathiak M, Rütten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, Propping P, Kruse R: Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: Establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002, 26: 338-343. 10.1097/00000478-200203000-00007.CrossRefPubMed Mathiak M, Rütten A, Mangold E, Fischer HP, Ruzicka T, Friedl W, Propping P, Kruse R: Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: Establishment of immunohistochemical analysis as a screening test. Am J Surg Pathol. 2002, 26: 338-343. 10.1097/00000478-200203000-00007.CrossRefPubMed
15.
go back to reference Suspiro A, Fidalgo P, Cravo M, Albuquerque C, Ramalho E, Leitao CN, Costa Mira F: The Muir-Torre syndrome: a rare variant of hereditary non-polyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol. 1998, 93: 1572-1574. 10.1111/j.1572-0241.1998.00487.x.CrossRefPubMed Suspiro A, Fidalgo P, Cravo M, Albuquerque C, Ramalho E, Leitao CN, Costa Mira F: The Muir-Torre syndrome: a rare variant of hereditary non-polyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol. 1998, 93: 1572-1574. 10.1111/j.1572-0241.1998.00487.x.CrossRefPubMed
16.
go back to reference Graefe T, Wollina U, Schulz H, Burgdorf W: Muir-Torre syndrome-treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000, 200: 331-333. 10.1159/000018399.CrossRefPubMed Graefe T, Wollina U, Schulz H, Burgdorf W: Muir-Torre syndrome-treatment with isotretinoin and interferon alpha-2a can prevent tumour development. Dermatology. 2000, 200: 331-333. 10.1159/000018399.CrossRefPubMed
Metadata
Title
Sebaceous gland tumors and internal malignancy in the context of Muir-Torre syndrome. A case report and review of the literature
Authors
K Tsalis
K Blouhos
K Vasiliadis
T Tsachalis
S Angelopoulos
D Betsis
Publication date
01-12-2006
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2006
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-4-8

Other articles of this Issue 1/2006

World Journal of Surgical Oncology 1/2006 Go to the issue